<?xml version='1.0' encoding='utf-8'?>
<document id="26460786"><sentence text="Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy." /><sentence text="Many antiepileptic drugs (AEDs) have the potential to cause teratogenicity" /><sentence text=" We evaluated eight antiepileptic drugs (AEDs) classified as Federal Drug Administration (FDA) pregnancy category D, X, or N designations and having documented teratogenic effects" /><sentence text=" These include carbamazepine, ethosuximide, fosphenytoin, phenobarbital, phenytoin, primidone, topiramate, and valproate"><entity charOffset="15-28" id="DDI-PubMed.26460786.s4.e0" text="carbamazepine" /><entity charOffset="30-42" id="DDI-PubMed.26460786.s4.e1" text="ethosuximide" /><entity charOffset="44-56" id="DDI-PubMed.26460786.s4.e2" text="fosphenytoin" /><entity charOffset="58-71" id="DDI-PubMed.26460786.s4.e3" text="phenobarbital" /><entity charOffset="73-82" id="DDI-PubMed.26460786.s4.e4" text="phenytoin" /><entity charOffset="84-93" id="DDI-PubMed.26460786.s4.e5" text="primidone" /><entity charOffset="95-105" id="DDI-PubMed.26460786.s4.e6" text="topiramate" /><entity charOffset="111-120" id="DDI-PubMed.26460786.s4.e7" text="valproate" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e0" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e1" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e2" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e3" e2="DDI-PubMed.26460786.s4.e3" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e3" e2="DDI-PubMed.26460786.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e3" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e3" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e3" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e4" e2="DDI-PubMed.26460786.s4.e4" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e4" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e4" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e4" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e5" e2="DDI-PubMed.26460786.s4.e5" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e5" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e5" e2="DDI-PubMed.26460786.s4.e7" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e6" e2="DDI-PubMed.26460786.s4.e6" /><pair ddi="false" e1="DDI-PubMed.26460786.s4.e6" e2="DDI-PubMed.26460786.s4.e7" /></sentence><sentence text=" Women with epilepsy (WWE) may need one or more of these AEDs for seizure control but may be unaware of the potential teratogenicity associated with their use" /><sentence text=" In utero exposure to AEDs increases the risks for both congenital malformations and other teratogenic defects" /><sentence text=" Given that approximately 50% of pregnancies are unintended, it is likely that women with epilepsy taking these medications could unknowingly put a growing fetus at risk" /><sentence text=" For women using contraception while taking these medications, many choose combined hormonal contraceptives (CHCs)" /><sentence text=" Drug-drug interactions exist between AEDs and CHCs that may decrease contraceptive efficacy" /><sentence text=" The aim of this study was to evaluate prescribing patterns for potentially teratogenic AEDs and contraceptive use in WWE of childbearing ability, including those with potential drug-drug interactions" /><sentence text=" This study also determined the number of WWE of childbearing ability prescribed potentially teratogenic AEDs and documentation of a pregnancy or contraception plan" /><sentence text="" /><sentence text="This was a retrospective, observational study of WWE age 15-44 years, of childbearing ability, prescribed an AED from July 1, 2011 to June 30, 2012, and who had an appointment at the University of Colorado Hospital Outpatient Neurology Clinic (Anschutz Medical Campus)" /><sentence text="" /><sentence text="One hundred fifteen women with an average age of 30" /><sentence text="7 years and various types of seizures were evaluated" /><sentence text=" The majority of patients were prescribed topiramate (34/115, 30%) or carbamazepine (27/115, 23%)"><entity charOffset="42-52" id="DDI-PubMed.26460786.s17.e0" text="topiramate" /><entity charOffset="70-83" id="DDI-PubMed.26460786.s17.e1" text="carbamazepine" /><pair ddi="false" e1="DDI-PubMed.26460786.s17.e0" e2="DDI-PubMed.26460786.s17.e0" /><pair ddi="false" e1="DDI-PubMed.26460786.s17.e0" e2="DDI-PubMed.26460786.s17.e1" /></sentence><sentence text=" Of the women, 30/115 (26%) had a documented contraception method when taking a potentially teratogenic AED" /><sentence text=" Of these women prescribed contraception, most (18/30, 60%) used an oral combined hormonal contraceptive or progestin-only pill, a majority of which had a potential for a drug-drug interaction with their AEDs (16/18, 89%)"><entity charOffset="108-117" id="DDI-PubMed.26460786.s19.e0" text="progestin" /></sentence><sentence text=" Less than 7% of women received counseling on a contraception plan, and 18% of subjects received counseling on a pregnancy plan" /><sentence text="" /><sentence text="Most WWE of childbearing ability taking potentially teratogenic AEDs were not using contraception" /><sentence text=" Those using contraception frequently had a method that has a significant drug-drug interaction which reduces the effectiveness of contraception" /><sentence text=" Women with epilepsy of childbearing ability prescribed an AED should be using effective contraception or participating in active discussions about pregnancy planning to avoid unplanned pregnancies and possible teratogenic effects of these AEDs" /><sentence text=" Documentation about pregnancy planning or contraceptive use in WWE of childbearing ability is minimal and should be discussed at least annually" /><sentence text=" It is critical for providers to discuss with WWE of childbearing ability the benefits and risks of various AED treatments; the need to select appropriate, effective contraception when pregnancy is not desired; and the importance of counseling regarding contraceptive or pregnancy planning" /><sentence text="" /></document>